Heuts S, Kawczynski MJ, Maesen B, & Vriesendorp PA. (2025). When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation. Heart (British Cardiac Society), 111(20), 947-947. https://doi.org/10.1136/heartjnl-2025-326208

HEUTS S, KAWCZYNSKI MJ, MAESEN B und VRIESENDORP PA, 2025. When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation. Heart (British Cardiac Society). 25 September 2025. Vol. 111, no. 20, p. 947-947. DOI 10.1136/heartjnl-2025-326208.

Heuts S, Kawczynski MJ, Maesen B, und Vriesendorp PA. „When Absence of Evidence Equates to Evidence of Absence: The Case of Routine Use of Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Implantation.“. Heart (British Cardiac Society), Bd. 111, Nr. 20, September 2025, S. 947-, https://doi.org/10.1136/heartjnl-2025-326208.

Heuts S/Kawczynski MJ/Maesen B/Vriesendorp PA: When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation., Heart (British Cardiac Society) 2025, 947-947.

Heuts S, Kawczynski MJ, Maesen B und Vriesendorp PA. (2025), „When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantation.“, Heart (British Cardiac Society), Vol. 111 No. 20, S. 947-947.